[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,439
Citations 0
Comment & Response
July 12, 2016

Management of Community-Acquired Pneumonia

Author Affiliations
  • 1Infectious Diseases Institute, Rambam Health Care Campus, Haifa, Israel
  • 2Unit of Infectious Diseases, Rabin Medical Center, Petah-Tikva, Israel
  • 3Medicine E, Rabin Medical Center, Petah-Tikva, Israel

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2016;316(2):220-221. doi:10.1001/jama.2016.5013

To the Editor Dr Lee and colleagues1 addressed several important questions in their review of the management of community-acquired pneumonia. We have concerns about the analysis of time to first antibiotic dose and the conclusions inferred from the use of observational studies.

For the time to first antibiotic dose, the authors found only observational studies and included only those adjusting the mortality analysis for other risk factors. Exclusion of studies that did not report an adjusted association estimate disregards studies in which there was no association between time to antibiotic initiation and mortality in the bivariable analysis and therefore did not enter the variable into the adjusted analysis. Another analysis including such studies showed no association between time to first antibiotic dose and mortality.2